M. Zucker

发表

Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency

A. Wolberg, U. Seligsohn, O. Salomon, 2014, Journal of thrombosis and haemostasis : JTH.

Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis

D. Steinberg, D. Varon, U. Seligsohn, 2010, Thrombosis and Haemostasis.

Point mutations regarded as missense mutations cause splicing defects in the factor XI gene

F. Bauduer, A. Zivelin, N. Rosenberg, 2011, Journal of thrombosis and haemostasis : JTH.

An allosteric disulfide bond is involved in enhanced activation of factor XI by protein disulfide isomerase

A. Yeheskel, U. Seligsohn, R. Mor-cohen, 2016, Journal of thrombosis and haemostasis : JTH.

Three residues at the interface of factor XI (FXI) monomers augment covalent dimerization of FXI

M. Landau, N. Rosenberg, U. Seligsohn, 2009, Journal of thrombosis and haemostasis : JTH.

Platelet factor XI: intracellular localization and mRNA splicing following platelet activation.

N. Rosenberg, U. Seligsohn, H. Hauschner, 2017, Blood cells, molecules & diseases.

The reduced form of coagulation factor XI is associated with illness severity and coagulopathy in critically-ill septic patients

Samuel M. Brown, Robert A. Campbell, M. Rondina, 2019, Journal of Thrombosis and Thrombolysis.

Induction of an inhibitor antibody to factor XI in a patient with severe inherited factor XI deficiency by Rh immune globulin.

J. Teitel, U. Seligsohn, A. Zivelin, 2008, Blood.

Characterization of seven novel mutations causing factor XI deficiency

M. Landau, F. Bauduer, G. Kenet, 2007, Haematologica.

Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews

H. Peretz, R. Mor-cohen, S. Usher, 2013, Journal of thrombosis and haemostasis : JTH.